Commission Implementing Regulation (EU) 2015/984 of 24 June 2015 approving copper pyrithione as an existing active substance for use in biocidal products for product-type 21 (Text with EEA relevance)
Commission Implementing Regulation (EU) 2015/984 of 24 June 2015 approving copper pyrithione as an existing active substance for use in biocidal products for product-type 21 (Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products(1), and in particular the third subparagraph of Article 89(1) thereof,
Whereas:
Commission Delegated Regulation (EU) No 1062/2014(2) establishes a list of existing active substances to be evaluated for their possible approval for use in biocidal products.
That list includes copper pyrithione.
Copper pyrithione has been evaluated in accordance with Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council(3) for use in product-type 21, antifouling products, as defined in Annex V to that Directive, which correspond to product-type 21, as defined in Annex V to Regulation (EU) No 528/2012.
Sweden was designated as evaluating competent authority and submitted an assessment report, together with its recommendations, to the Commission on 28 January 2011 in accordance with paragraphs 4 and 6 of Article 14 of Commission Regulation (EC) No 1451/2007(4).
In accordance with Article 7(1)(b) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 3 October 2014 by the Biocidal Product Committee, having regard to the conclusions of the evaluating competent authority.
According to that opinion, biocidal products used for product-type 21 and containing copper pyrithione may be expected to satisfy the requirements laid down in Article 5 of Directive 98/8/EC provided that certain conditions concerning its use are complied with.
It is therefore appropriate to approve copper pyrithione for use in biocidal products for product-type 21 subject to compliance with the specific conditions in the Annex.
The acceptability of the risks related to the use of antifouling products, as well as the suitability of the proposed risk mitigation measures, needs to be further confirmed. In order to facilitate, at the time of the renewal of the approvals of existing antifouling active substances, the review and comparison of the risks and benefits of those substances as well as of the risk mitigation measures applied, the expiry date of approval of those substances should be the same.
A reasonable period should be allowed to elapse before an active substance is approved, in order to permit interested parties to take the preparatory measures necessary to meet the new requirements.
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,
HAS ADOPTED THIS REGULATION:
Article 1
Copper pyrithione is approved as an active substance for use in biocidal products for product-type 21, subject to the specifications and conditions set out in the Annex.
Article 2
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 24 June 2015.
For the Commission
The President
Jean-Claude Juncker
ANNEX
Common Name | IUPAC Name Identification Numbers | Minimum degree of purity of the active substance(1) | Date of approval | Expiry date of approval | Product type | Specific conditions |
---|---|---|---|---|---|---|
Copper pyrithione | IUPAC Name: bis(1-hydroxy-1H-pyridine-2-thionato-O,S)copper EC No: 238-984-0 CAS No: 14915-37-8 | 950 g/kg | 1 October 2016 | 31 December 2025 | 21 | The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance. The authorisations of biocidal products are subject to the following conditions:
|